Europe Protein A Resin Market Report Description:
Europe Protein A Resin market report gives comprehensive outlook on protein a resin usage across the regions with special emphasis on key countries such as Germany, France, U.K, Italy, Spain, Russia, and Poland. The report on Protein A Resin market gives historical, current, and future market sizes (US$ Mn) on the basis of device type, application, end users, and country. Europe Protein A Resin market report presents the market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Europe Protein A Resin market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Europe Protein A Resin market to better equip clients with possible investment opportunities across the countries (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the Europe Protein A Resin market report include component suppliers, manufacturers, marketers, hospitals, physician offices, policy makers, and healthcare service providers, who are engaged in usage and advocacy of Protein A Resin.
Europe Protein A Resin Market:
Europe Protein A Resin market was valued around US$ 110 Mn in 2016 and poised to grow around 9.0% CAGR over 2017-2023.
Competition Assessment
Key players profiles in the Europe Protein A Resin market include:

  • Novasep Holding SAS (U.S.)
  • GE Healthcare (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Merck KGaA (Germany)
  • JSR Corporation (Japan)
  • Tosoh Corporation (Japan)
  • Repligen Corporation (U.S.)
  • Expedeon Ltd. (U.S.)
  • GenScript (U.S.)

Players in the Europe Protein A Resin market are entering into partnerships and collaborations, launching newer products in the market to garner larger market share

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

Product Type

  • ·Natural Protein A Resin
  • ·Recombinant Protein A Resin

Matrix Type

  • ·Glass or Silica
  • ·Agarose
  • ·Organic Polymer


  • ·Immunoprecipitation (IP)
  • ·Antibody Purification

End User

  • ·Biopharmaceutical Companies
  • ·Clinical Research Laboratories
  • ·Academic Institutes


  • ·Germany
  • ·France
  • ·U.K
  • ·Italy
  • ·Spain
  • ·Russia
  • ·Poland
  • ·Rest of Europe